After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth Group struck a positive note about its acquisition of Amedisys during its annual meeting of shareholders on ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper ...

A spokesperson for UnitedHealth Group said. "The Guardian refused to engage with the truth and chose instead to print its ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

UnitedHealth Group (NYSE: UNH) signaled confidence in its merger with Amedisys (Nasdaq: AMED) in a document prepared for shareholders. An earlier draft of ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...